Anderson Matheus Pereira Pereira da Silva is an expert in Neurology at Federal University of Pernambuco (Brazil). Anderson Matheus Pereira Pereira da Silva has authored 9 publications, the most recent in 2025. SLR score: 103 (community average: 125). How the SLR is computed.

LeadR Profile

Anderson Matheus Pereira Pereira da Silva Federal University of Pernambuco Brazil
103 ScienceLeadR Reputation 103
Network Map

Neurology

Subspecialties: Psychiatry - Cardiology - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Graduated in Pharmacy from the Federal University of Vale do São Francisco (2023), with a specialization in Clinical Pharmacy and Pharmaceutical Prescription (2024). He is a member of the American Academy of Neurology (AAN), and the British Pharmacological Society. Currently, he is a PhD student in Biotechnology (RENORBIO/UFPE). Associate Editor of the Journal of Alzheimer’s Disease.

Organizations

Career arc: 2025 - 2030

Source: PubMed

Universidade Federal de Pernambuco

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 9

Citations

Citations: 0 1st author: 7 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Corticotherapy versus adrenocorticotropic hormone for treating West syndrome: a systematic review and meta-analysis.
PMID 40886708 — hypertension, spasm, adrenal cortex hormones, hormones, odds ratio, therapeutics, adrenocorticotropic hormone, spasms, infantile, infections, child, psychiatry
Arq Neuropsiquiatr20250
Brexpiprazole for the Treatment of Agitation in Older Adults with Alzheimer's Disease: A Systematic Review, Bayesian Meta-analysis, and Meta-regression.
PMID 40886227 — safety, alzheimer disease, signs and symptoms, therapeutics
CNS Drugs20250
Efficacy and Safety of Escitalopram and Citalopram for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PMID 40842389 — dementia, safety, alzheimer disease, drug-related side effects and adverse reactions, citalopram, therapeutics, nervous system diseases
J Geriatr Psychiatry Neurol20250
Efficacy, Immunogenicity, Safety, and Tolerability of AADvac1 in Alzheimer Disease: A Systematic Review and Meta-Analysis of Placebo-Controlled Trials.
PMID 40820539 — safety, alzheimer disease
Alzheimer Dis Assoc Disord20250
Optimal duration of dual antiplatelet therapy after endovascular treatment of intracranial aneurysms with stenting: a systematic review and meta-analysis.
PMID 40742483 — safety, hemorrhage, aneurysm, radiography, retreatment, therapeutics, intracranial aneurysm
Neuroradiology20250

LeadR Networks

Main global connection map